Characterization and inhibition of a cholecystokinin-inactivating serine peptidase

Nature
C RoseJ C Schwartz

Abstract

A cholecystokinin (CCK)-inactivating peptidase was purified and identified as a membrane-bound isoform of tripeptidyl peptidase II (EC 3.4.14.10), a cytosolic subtilisin-like peptidase of previously unknown functions. The peptidase was found in neurons responding to cholecystokinin, as well as in non-neuronal cells. Butabindide, a potent and specific inhibitor, was designed and shown to protect endogenous cholecystokinin from inactivation and to display pro-satiating effects mediated by the CCKA receptor.

References

Oct 26, 1977·Biochimica Et Biophysica Acta·E M DanielsenE Dabelsteen
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J HughesG N Woodruff
Jan 1, 1991·Annual Review of Pharmacology and Toxicology·G N Woodruff, J Hughes
Mar 1, 1989·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M G Low
Jan 1, 1988·Annual Review of Biochemistry·M A Ferguson, A F Williams
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C RoseJ C Schwartz
Jan 1, 1986·Neuropeptides·C DurieuxB P Roques
Aug 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·C Llorens-CortesJ C Schwartz
Apr 14, 1987·Biochemical and Biophysical Research Communications·B MalfroyW J Henzel
Sep 1, 1985·Journal of Neurochemistry·L SteardoT N Chase
Jul 14, 1966·Annals of the New York Academy of Sciences·V P Whittaker
Apr 20, 1967·Biochemical and Biophysical Research Communications·I Schechter, A Berger
Mar 23, 1994·Annals of the New York Academy of Sciences·G P Smith, J Gibbs
Jul 1, 1993·Progress in Neurobiology·J MassouliéF M Vallette
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Jan 1, 1983·Neurochemistry International·J R McDermottA I Smith

❮ Previous
Next ❯

Citations

Mar 26, 2003·American Journal of Physical Anthropology·Philip Lieberman
Jun 1, 1997·Journal of Clinical Pharmacology·M WeiserM A Abdeen
Aug 30, 2005·The International Journal of Biochemistry & Cell Biology·Birgitta Tomkinson, Ann-Christin Lindås
Nov 25, 2003·Leukemia Research·Izabela MłnarczukJakub Gołab
Nov 11, 1998·Neuroscience and Biobehavioral Reviews·V Daugé, I Léna
Jul 4, 1998·Brain Research. Brain Research Reviews·M ZoliL F Agnati
Dec 21, 2000·Trends in Pharmacological Sciences·B P Roques
Jun 15, 1999·Progress in Neurobiology·F Noble, B P Roques
Mar 19, 1999·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·M BourinE Vasar
Sep 2, 1999·Trends in Biochemical Sciences·B Tomkinson
Jan 1, 2003·Seminars in Cancer Biology·Nico P Dantuma, Maria G Masucci
Oct 3, 2002·Protein Expression and Purification·Lena BurriFrédéric Lévy
Nov 26, 2002·Biochimica Et Biophysica Acta·Hubert HilbiBirgitta Tomkinson
Jan 1, 1996·Parasitology·D P ThompsonT G Geary
Mar 31, 2012·Nature Reviews. Drug Discovery·Bernard P RoquesMichel Wurm
Aug 3, 2010·Nature Structural & Molecular Biology·Crystal K ChuangBing K Jap
Mar 5, 2002·European Journal of Biochemistry·Birgitta TomkinsonKimberly Wellington
Oct 2, 2003·European Journal of Biochemistry·Elisabeth BonnardJean-Marie Zajac
Aug 7, 1997·The New England Journal of Medicine·M RosenbaumJ Hirsch
Aug 3, 2001·The EMBO Journal·A M Lennon-DuménilP Wolf Bryant
May 24, 2005·Plant Physiology·Adam J BookRichard D Vierstra
Jul 27, 2001·Biochemical and Biophysical Research Communications·M T ChâteauO Coux
Jul 12, 2005·Proceedings of the National Academy of Sciences of the United States of America·Beate RockelWolfgang Baumeister
Aug 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·E W WangR Glas
Jan 24, 2012·Biochimica Et Biophysica Acta·Sandra EklundBirgitta Tomkinson
Jul 10, 2012·Biochemical and Biophysical Research Communications·Sandra EklundBirgitta Tomkinson
Sep 15, 2009·Biochemical and Biophysical Research Communications·Giulio PretaRickard Glas
Jun 30, 2009·Pharmacology & Therapeutics·Marianne T Neary, Rachel L Batterham
May 27, 2009·Archives of Biochemistry and Biophysics·Sandra ErikssonBirgitta Tomkinson
Sep 30, 2008·Biochimica Et Biophysica Acta·Ann-Christin LindåsBirgitta Tomkinson
Oct 26, 2005·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·T J LittleC Feinle-Bisset
Jul 6, 2004·Immunological Reviews·Mark Howarth, Tim Elliott
Oct 13, 2007·EMBO Reports·Renée M McKayJonathan M Graff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.